PS
IRMD icon

Principal Securities’s iRadimed IRMD Stock Holding History

Principal Securities’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100
Closed -$7.12K – 2443
2025
Q3 		$7.12K Sell
100
-6
-6% -$400 ﹤0.01% 2844
2025
Q2 		$6.34K Buy
106
+9
+9% +$493 ﹤0.01% 2796
2025
Q1 		$5.33K Hold
97
– – ﹤0.01% 2755
2024
Q4 		$5.33K Buy
97
+15
+18% +$789 ﹤0.01% 2752
2024
Q3 		$4.12K Buy
82
+5
+6% +$231 ﹤0.01% 2738
2024
Q2 		$3.38K Buy
77
+28
+57% +$1.19K ﹤0.01% 2769
2024
Q1 		$2.16K Buy
+49
New +$2.17K ﹤0.01% 2858

Other funds holding IRMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Principal Securities's IRMD Position: Q4 2025 in Review

Principal Securities sold out of iRadimed (IRMD) in Q4 2025, closing a stake of 100 shares — an estimated $7.12K sold.

Principal Securities first reported a position in IRMD in Q1 2024 and held it in 7 quarters. The position peaked at $7.12K in Q3 2025. 217 funds tracked by Wall St. Rank hold IRMD as of Q4 2025.

  • Principal Securities reported no remaining iRadimed position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 100 iRadimed shares in Q4 2025, an estimated $7.12K.
  • Principal Securities first reported a position in iRadimed in Q1 2024 and held it in 7 quarters.
  • Principal Securities's iRadimed position peaked at $7.12K in Q3 2025.
  • 217 funds tracked by Wall St. Rank held iRadimed as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.